Upgrade to SI Premium - Free Trial

Form SCHEDULE 13G/A Context Therapeutics Filed by: Blue Owl Capital Holdings LP

May 14, 2026 4:21 PM





Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G




Comment for Type of Reporting Person: The reported percentage is calculated based on 91,879,177 shares of Common Stock outstanding as of May 4, 2026, as reported on the Issuer's 10-Q filed with the Securities and Exchange Commission on May 6, 2026.


SCHEDULE 13G



Blue Owl Capital Holdings LP
Signature:/s/ Karen Hager
Name/Title:Karen Hager / Chief Compliance Officer
Date:05/13/2026

Categories

SEC Filings